main content start
Press release
Local Press Releases
Press release
Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes
The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (…
Press release
Access to Continuous Glucose Monitors in Pediatric Diabetes Populations Improves Glycemic Control, Reduces Hypoglycemia and Improves Satisfaction with Diabetes Care and Technology Use
Diabetes requires management 24 hours a day, seven days a week, 365 days of the year and presents numerous daily challenges, particularly…
Press release
Linagliptin and Glimepiride Have Comparable Cardiovascular Safety Effects in Type 2 Diabetes at High Cardiovascular Risk
The diabetes medications glimepiride and linagliptin had similar impacts on cardiovascular morbidity and mortality for a median period of…
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.